Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H11NO5.C4H11NO |
| Molecular Weight | 278.3022 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCO.CC(=O)N[C@@H](CCC(O)=O)C(O)=O
InChI
InChIKey=WKAVKKUXZAWHDM-JEDNCBNOSA-N
InChI=1S/C7H11NO5.C4H11NO/c1-4(9)8-5(7(12)13)2-3-6(10)11;1-5(2)3-4-6/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13);6H,3-4H2,1-2H3/t5-;/m0./s1
| Molecular Formula | C4H11NO |
| Molecular Weight | 89.1362 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C7H11NO5 |
| Molecular Weight | 189.1659 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Deanol is a chemical compound that is involved in the biosynthesis of the neurotransmitter acetylcholine. Deanol aceglumate is marketed in Russia as a hepatoprotector and neurometabolic stimulator for the treatment of asthenic and astheno-depressive disorders, neuroleptic syndrome, alcohol withdrawal syndrome, neurotic and neurosis-like disorders, acute and chronic hepatitis, cirrhosis of the liver, cholestasis, fatty liver dystrophy of various genesis.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:31 GMT 2025
by
admin
on
Mon Mar 31 18:23:31 GMT 2025
|
| Record UNII |
2PP737Z523
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
48780
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
2PP737Z523
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
3342-61-8
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
222-085-5
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
71125
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
100000083468
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
C043253
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
1638
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
m4115
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
C76620
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
DTXSID10955037
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY | |||
|
SUB06926MIG
Created by
admin on Mon Mar 31 18:23:31 GMT 2025 , Edited by admin on Mon Mar 31 18:23:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
